Aristeia Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
+48,141
New +$537K 0.01% 422
2026
Q1
Sell
-75,174
Closed -$749K 699
2025
Q4
$749K Buy
+75,174
New +$718K 0.02% 263
2024
Q2
Sell
-33,245
Closed -$383K 340
2024
Q1
$383K Buy
+33,245
New +$282K 0.01% 124
2019
Q4
Sell
-1,319,551
Closed -$13.4M 55
2019
Q3
$13.4M Buy
+1,319,551
New +$13.5M 0.78% 23

Other funds holding AHCO

Aristeia Capital's AHCO Position: Q2 2026 in Review

Aristeia Capital opened a new position in AdaptHealth (AHCO) in Q2 2026: 48,141 shares worth $502K. The stake represents 0.01% of the portfolio and ranks #422 among its holdings. This is a return to the name: Aristeia Capital previously reported a position in AHCO as recently as Q4 2025.

Aristeia Capital first reported a position in AHCO in Q3 2019 and has held it in 4 quarters since. The position peaked at $13.4M in Q3 2019. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Aristeia Capital held 48,141 shares of AdaptHealth worth $502K as of Q2 2026.
  • AdaptHealth was a new Aristeia Capital position in Q2 2026.
  • AdaptHealth made up 0.01% of Aristeia Capital's portfolio in Q2 2026, its #422 holding.
  • Aristeia Capital first reported a position in AdaptHealth in Q3 2019 and has held it in 4 quarters since.
  • Aristeia Capital's AdaptHealth position peaked at $13.4M in Q3 2019.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.